Itinai.com biomedical laboratory close up still scene close u 2a5a1238 15e1 44d7 ad99 fe42b30c4e72 1
Itinai.com biomedical laboratory close up still scene close u 2a5a1238 15e1 44d7 ad99 fe42b30c4e72 1

Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial

Six-month Coenzyme Q10 Supplementation Improves Liver and Cardiovascular Function

Study Overview

A clinical trial assessed the effects of coenzyme-Q10 supplementation on patients with Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD).

Results

After six months, patients receiving coenzyme-Q10 showed significant improvements in various measures, including reduced liver steatosis, improved endothelial and vascular function, and enhanced myocardial function.

Practical Solutions

These findings suggest that high-dose coenzyme-Q10 supplementation can lead to notable improvements in micro- and macro-vasculature function, offering potential benefits for patients with MASLD.

Value

This study highlights the potential value of coenzyme-Q10 supplementation in improving liver and cardiovascular function in patients with MASLD, providing insights for clinical practice and patient care.

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research